Skip to main content
. 2026 Jun;32(6):704–716. doi: 10.18553/jmcp.2026.32.6.704

TABLE 4.

Comparison of All-Cause Health Care Costs Between Patients With and Without Recurrence

All-cause health care costs Resected Unresected
Adjusted monthly cost differencea 95% CI Adjusted monthly cost differencea 95% CI
Total costs, 2023 USD 3,831 (2,319-5,360) 4,730 (3,611-5,870)
 Medical costs 3,732 (2,232-5,247) 4,649 (3,541-5,779)
 Part D pharmacy costs 92 (−11-198) 340 (17-636)
a

Monthly cost differences and P values were estimated using univariable generalized linear models with a Tweedie distribution (a compound Poisson-gamma distribution) and log-link function. The adjusted models controlled for age at index date, sex (reference: male), race (reference: White), region (reference: west), Charlson comorbidity index, disease stage at diagnosis (reference: stage III), cancer site (reference: oropharynx), primary treatment (reference: surgery only), and corresponding costs during the baseline period. A monthly cost difference greater than 0 indicates patients with recurrence incurred more health care costs than patients without recurrence.

USD = United States dollars.